0001638234-15-000001.txt : 20150402 0001638234-15-000001.hdr.sgml : 20150402 20150402102201 ACCESSION NUMBER: 0001638234-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150402 DATE AS OF CHANGE: 20150402 EFFECTIVENESS DATE: 20150402 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Acer Therapeutics Inc. CENTRAL INDEX KEY: 0001638234 IRS NUMBER: 320426967 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-237187 FILM NUMBER: 15745796 BUSINESS ADDRESS: STREET 1: 222 THIRD STREET, SUITE 2240 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-922-3600 MAIL ADDRESS: STREET 1: 222 THIRD STREET, SUITE 2240 CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0707 D LIVE 0001638234 Acer Therapeutics Inc. 222 THIRD STREET, SUITE 2240 CAMBRIDGE MA MASSACHUSETTS 02142 617-225-7700 DELAWARE None None Corporation true 2013 Harry S. Palmin c/o Acer Therapeutics Inc. 222 Third Street, Suite 2240 Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Promoter Christopher Schelling c/o Acer Therapeutics Inc. 222 Third Street, Suite 2240 Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Promoter Cynthia Lavoie c/o Acer Therapeutics Inc. 222 Third Street, Suite 2240 Cambridge MA MASSACHUSETTS 02142 Director Pharmaceuticals Decline to Disclose 06b false 2015-03-20 false true true false 0 2100000 2100000 0 false 2 0 0 290000 true The Issuer expects to use $290,000 of the proceeds for salary payments to the Issuer's Executive Officers, Harry S. Palmin and Christopher Schelling. false Acer Therapeutics Inc. /s/ Harry S. Palmin Harry S. Palmin President & CEO 2015-04-01